NEW YORK (GenomeWeb News) – Oligonucleotide synthesis company Integrated DNA Technologies announced today that it has purchased VH Bio's oligonucleotide business.

Under the agreement, IDT will serve VH Bio's oligonucleotide customers from IDT's European synthesis facility, which opened in Leuven, Belgium, this past September. As such, IDT plans to provide current VH Bio customers with a broader product range of quality-controlled oligonucleotides that are available for next-day delivery.
Financial terms of the agreement were not disclosed.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

A fire at a Manchester hospital may have destroyed lab equipment and data, the Guardian reports.

Researchers generate a genetic database from skeletal remains from the 1845 Franklin Expedition to the Arctic, Live Science reports.

Researchers in China have begun another trial using CRISPR/Cas9 approaches in cancer patients, according to the Wall Street Journal.

In Science this week: human DNA found in sediments from archeological sites lacking bones, and more.